Shire Plc Ads (SHPG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 303.36m
  • Volume: 0

Shire Plc Ads Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.
Competitors: ProStrakan, GlaxoSmithKline, Asterand, AstraZeneca, Skyepharma
Brands: Adderall, Carbatrol, Fluviral,

Key Personnel

CEO: Flemming Ornskov
CFO: Thomas Dittrich
Chairman: Susan Kilsby
Senior Independent Director: Olivier Bohuon
Non-Executive Dir: Ian Clark, Sara Mathew, Steven Gillis, Gail D. Fosler , David Ginsburg, Albert P.L. Stroucken

Contact Details

Address: 22 Grenville Street, St Helier, Jersey, JE4 8PX
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: http://www.shire.com

Listings

Index: Nasdaq 100
Overseas Listings: BATSLON:SHPL
ISIN: US82481R1068

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Shire Plc Ads Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 303.36m

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Shire Plc Ads Key Personnel

Chair Susan Kilsby
CEO Flemming Ornskov
CFO Thomas Dittrich

Top of Page